ZAP Surgical Announces US$81 Million Financing RoundHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)ZAP Surgical Announces US$81 Million Financing RoundPR NewswireJanuary 9, 2020ReblogShareTweetShareFunds Will Be Used to Accelerate Commercialization of the ZAP-X Robotic Surgical Platform for Non-Invasive Treatment of Brain Tumors Affecting More Than 2 Million Cancer Patients WorldwideSAN CARLOS, Calif., Jan. 8, 2020 /PRNewswire/ -- ZAP Surgical Systems, Inc., a medical technology company developing a next-generation radiosurgical robot for non-invasive tumor ablation, today announced the completion of an equity financing round that raised an aggregate total of US$81 million. The round was led by Primavera Capital Group, with participation from GT Healthcare Capital Partners, Chow Tai Fook Enterprises, ShangBay Capital, and Hogy Medical, who joined existing investors Foxconn Technology Group and Varian Medical Systems. The Company has now raised more than US$160 million in financing capital to date. Funds from the latest financing round will be used to accelerate the commercialization of the Company's FDA cleared ZAP-X® surgical robot for the treatment of cancer and other brain disorders.ZAP-X® Gyroscopic Radiosurgery™ platformMore"Although over the past 3 decades stereotactic radiosurgery has become a well-established non-invasive tool for treating a broad array of human pathologies, globally more than 2 million people who suffer from brain, head & neck cancer annually go untreated," said John R. Adler, MD, Stanford Professor of Neurosurgery and founder & CEO of ZAP Surgical Systems. "ZAP Surgical welcomes this group of world-class investors in our now common quest to transform the lives, and very often cure, millions of patients each year by means of the ZAP-X surgical robot.""We are very excited to be a part of this highly promising, innovative, mission-driven medical device company at an early stage in its commercial development," said Dr. Fred Hu, Chairman and Founder of Primavera Capital Group. "Dr. Adler is a true visionary in this field, and his team's latest invention will provide cutting-edge technology to millions of patients around the world. It fits Primavera's mission of supporting entrepreneurs who combine both commercial success and social impact globally."The ZAP-X platform is an integrated robotic software and hardware solution currently FDA-cleared to provide image-guided stereotactic radiosurgery for tumors, lesions and conditions in the brain, head and neck. ZAP-X incorporates a unique self-shielded design that typically eliminates the need for costly radiation bunkers. Combining this first-in-kind vault-free design with cobalt-free radiation delivery, the ZAP-X platform enables significant improvements to the delivery of cost-effective care with the goal of bringing world-class non-invasive radiosurgery to more providers, and subsequently, more patients.About ZAP Surgical Systems, Inc.ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X® radiosurgery platform. ZAP was founded in 2014 by John R. Adler, MD, Stanford Professor of Neurosurgery and founder & CEO of ZAP Surgical Systems. Dr. Adler is also the inventor of the CyberKnife® and founder of Accuray, Inc. FDA-cleared in September 2017, ZAP-X incorporates a unique self-shielded design that typically eliminates the need for traditional radiation vaults, and thus enables simple point-of-care delivery in locations previously unfeasible or cost-prohibitive, including physician offices, ambulatory surgery centers, and satellite facilities. Learn more at www.ZAPsurgical.com.Contact:Gabriel MorrisInvestor RelationsZAP Surgical Systems, Inc.Email: gabriel@zapsurgical.comMark ArnoldSenior Vice President, MarketingZAP Surgical Systems, Inc.Email: marka@zapsurgical.com CisionMoreView original content to download multimedia:http://www.prnewswire.com/news-releases/zap-surgical-announces-us81-million-financing-round-300984003.htmlSOURCE ZAP Surgical SystemsReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance Video'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceSomething 'dangerous' is happening beneath the surface of the market selloffYahoo FinanceBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'Yahoo FinanceWhat to watch in the markets: Friday, February 28Yahoo Finance VideoCoronavirus will wipe out corporate profit growth in 2020 and may trigger recession: Goldman SachsYahoo Finance